文献速递脑血管病

缺血性卒中后白蛋白水平与早期心血管并发症风险:全球联邦健康网络的倾向匹配分析

Albumin Levels and Risk of Early Cardiovascular Complications After Ischemic Stroke: A Propensity-Matched Analysis of a Global Federated Health Network.
PubMed 文献 · Stroke · 2024-02-07

该回顾性分析基于美国80家医疗机构的电子病历数据,纳入缺血性卒中患者,按入院白蛋白水平分为降低组(≤3.4 g/dL)和正常组(≥3.5 g/dL),经倾向评分匹配后比较30天内心血管并发症复合终点。结果显示白蛋白降低组主要结局发生率为36.0%,正常组为26.1%(HR 1.48,95%CI 1.46-1.50),各次要结局风险也均升高。作者认为白蛋白水平与早期心血管事件和死亡风险相关,其潜在病理生理或治疗作用需进一步研究。

要点

  • 缺血性卒中患者入院白蛋白≤3.4 g/dL者30天心血管复合结局风险高于正常组(HR 1.48)。
  • 白蛋白降低组全因死亡风险显著升高(HR 2.77),心肌梗死、心衰、房颤等风险亦升高。
  • 白蛋白水平与心血管事件风险的关联独立于高龄、性别、多病共存及其他低白蛋白血症原因。

核心结论

  • 白蛋白水平与缺血性卒中患者早期心血管事件和死亡风险相关。
  • 白蛋白在卒中患者中的潜在病理生理或治疗作用需进一步研究。

研究设计与样本

  • 回顾性分析,基于联邦研究网络(TriNetX)的电子病历数据,主要报告2000年至2023年间美国80家医疗机构的记录。
  • 根据入院时测定的白蛋白水平,将缺血性卒中患者分为降低组(≤3.4 g/dL)和正常组(≥3.5 g/dL)。
  • 采用倾向评分匹配后的Cox回归分析计算风险比(HR)和95%CI。

主要发现

  • 共320 111例白蛋白正常患者(70.9±14.7岁;女性48.9%)和183 729例(57.4%)白蛋白降低患者(72.9±14.3岁;女性50.3%)。
  • 倾向评分匹配后,主要结局在降低组发生率为36.0%,正常组为26.1%(HR 1.48,95%CI 1.46-1.50)。
  • 全因死亡风险在降低组更高(HR 2.77,95%CI 2.70-2.84)。
  • 心力衰竭风险在降低组更高(HR 1.31,95%CI 1.29-1.34);心房颤动风险在降低组更高(HR 1.11,95%CI 1.09-1.13)。
  • 室性心律失常风险在降低组更高(HR 1.38,95%CI 1.30-1.46);心肌梗死风险在降低组更高(HR 1.60,95%CI 1.54-1.65);Takotsubo心肌病风险在降低组更高(HR 1.51,95%CI 1.26-1.82)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: No studies have investigated the association between albumin levels and the risk of early cardiovascular complications in patients with ischemic stroke. METHODS: Retrospective analysis with a federated research network (TriNetX) based on electronic medical records (International Classification of Diseases-Tenth Revision-Clinical Modification and logical observation identifiers names and codes) mainly reported between 2000 and 2023, from 80 health care organizations in the United States. Based on albumin levels measured at admission to the hospital, patients with ischemic stroke were categorized into 2 groups: (1) reduced (≤3.4 g/dL) and (2) normal (≥3.5 g/dL) albumin levels. The primary outcome was a composite of all-cause death, heart failure, atrial fibrillation, ventricular arrhythmias, myocardial infarction, and Takotsubo cardiomyopathy 30 days from the stroke. Secondary outcomes were the risk for each component of the primary outcome. Cox regression analyses were used to calculate hazard ratios (HRs) and 95% CIs following propensity score matching. RESULTS: Overall, 320 111 patients with stroke had normal albumin levels (70.9±14.7 years; 48.9% females) and 183 729 (57.4%) had reduced albumin levels (72.9±14.3 years; 50.3% females). After propensity score matching, the primary outcomes occurred in 36.0% of patients with reduced and 26.1% with normal albumin levels (HR, 1.48 [95% CI, 1.46-1.50]). The higher risk in patients with reduced albumin levels was consistent also for all-cause death (HR, 2.77 [95% CI, 2.70-2.84]), heart failure (HR, 1.31 [95% CI, 1.29-1.34]), atrial fibrillation (HR, 1.11 [95% CI, 1.09-1.13]), ventricular arrhythmias (HR, 1.38 [95% CI, 1.30-1.46]), myocardial infarction (HR, 1.60 [95% CI, 1.54-1.65]), and Takotsubo cardiomyopathy (HR, 1.51 [95% CI, 1.26-1.82]). The association between albumin levels and the risk of cardiovascular events was independent of advanced age, sex, multimorbidity, and other causes of hypoalbuminemia. A progressively increased risk of adverse events was found in patients with mild and severe reduced compared to normal albumin levels. CONCLUSIONS: Albumin levels are associated with the risk of early cardiovascular events and death in patients with ischemic stroke. The potential pathophysiological or therapeutic roles of albumin in patients with stroke warrant further investigation.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Bucci T, Pastori D, Pignatelli P, et al. Albumin Levels and Risk of Early Cardiovascular Complications After Ischemic Stroke: A Propensity-Matched Analysis of a Global Federated Health Network. Stroke. 2024. PMID: 38323429. doi:10.1161/STROKEAHA.123.044248

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。